Remark Pharma Private Limited

Wholesale trading of medical and pharmaceutical products, including unique items, tablets, syrups, and injections.

2011 | Ranchi, Jharkhand (India) | Active
Last Updated:

Remark Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.18 M
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 2.50%
  • Profit Growth -165.94%
  • Ebitda 523.63%
  • Net Worth -2.63%
  • Total Assets 4.25%

About Remark Pharma

Remark Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2011 and has a history of 13 years and nine months. Its registered office is in Ranchi, Jharkhand, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.

Pawan Arya, Sangeeta Gupta, Kanchan Arya, and One other member serve as directors at the Company.

Company Details

  • Location

    Ranchi, Jharkhand, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231JH2011PTC014896

  • Company No.

    014896

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    06 Jun 2011

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Jharkhand

Industry

Pharma
Company report

Remark Pharma Private Limited

Explore comprehensive data for Remark Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Remark Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Pawan Arya Country flag representing In Director 11-May-2016Current
Sangeeta Gupta Country flag representing In Director 11-May-2016Current
Kanchan Arya Country flag representing In Director 06-Jun-2011Current
Deepak Kumar Country flag representing In Director 06-Jun-2011Current

Financial Performance of Remark Pharma.

Remark Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.5% increase. The company also saw a substantial fall in profitability, with a 165.94% decrease in profit. The company's net worth dipped by a decrease of 2.63%.

Remark Pharma revenue growth over time
Remark Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.50%
Revenue from Operations
4.54%
Total Assets
4.25%
Profit or Loss
-165.94%
Net Worth
-2.63%
EBITDA
523.63%

What is the Ownership and Shareholding Structure of Remark Pharma?

In 2019, Remark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Remark Pharma?

Unlock and access historical data on people associated with Remark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Remark Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Remark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remark Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Remark Pharma

Recent activity within the organization

  • Annual General Meeting

    Remark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Remark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jharkhand.

  • Director Appointment

    Pawan Kumar Arya was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 8 years 10 months .

  • Director Appointment

    Sangeeta Gupta was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 8 years 10 months .

  • Director Appointment

    Kanchan Arya was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 13 years 9 months .

  • Director Appointment

    Deepak Kumar was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 13 years 9 months .

Frequently asked questions

  • What is the Incorporation or founding date of Remark Pharma Private Limited?

    Remark Pharma Private Limited was incorporated on 06 Jun 2011.

  • What is authorized share capital and paid-up capital of Remark Pharma Private Limited?

    The authorized share capital of Remark Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.18 M.

  • Who are the current board members & directors of Remark Pharma Private Limited?

    Currently 4 directors are associated with Remark Pharma Private Limited.

    • Pawan Kumar Arya
    • Sangeeta Gupta
    • Kanchan Arya
    • Deepak Kumar
  • What is the registered address of Remark Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Remark Pharma Private Limited is Sri Bishwanath Bhawan Mo- Madhukam P.O.: Hehal P.S.: Sukhdeonagar, India, Ranchi, Jharkhand, 834005.

  • What is the corporate identification number (CIN) and company number of Remark Pharma Private Limited?

    The corporate identification number (CIN) of Remark Pharma Private Limited is U24231JH2011PTC014896 and the company number is 014896 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Remark Pharma Private Limited?

    The Official website of Remark Pharma Private Limited is https://www.remarkindia.com

  • What has been the recent revenue trend for Remark Pharma Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Remark Pharma Private Limited has risen by 2.50%.

  • What change has been observed in the net worth of Remark Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Remark Pharma Private Limited has experienced an downturn of -2.63%.

  • When was the last Balance Sheet of Remark Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Remark Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed